- Home
- VRDN vs MPT Comparison
VRDN vs MPT Comparison
Compare VRDN & MPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$30.11
N/A
Current Price
$5.73
Company Overview
Basic Information| Metric | VRDN | MPT |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VRDN | MPT |
|---|---|---|
| Price | $30.11 | $5.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $41.42 | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 6.6M |
| Earning Date | 02-26-2026 | 02-06-2026 |
| Dividend Yield | N/A | ★ 5.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $70,789,000.00 | ★ $1,009,160,000.00 |
| Revenue This Year | $26,080.80 | N/A |
| Revenue Next Year | $2.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23340.07 | 52.52 |
| 52 Week Low | $9.90 | $3.95 |
| 52 Week High | $34.29 | $6.34 |
Technical Indicators
Market Signals| Indicator | VRDN | MPT |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | N/A |
| Support Level | $28.92 | N/A |
| Resistance Level | $30.75 | N/A |
| Average True Range (ATR) | 1.47 | 0.00 |
| MACD | -0.40 | 0.00 |
| Stochastic Oscillator | 21.67 | 0.00 |
Price Performance
Historical Comparison VRDN
MPT
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).